Orion CEO Co-Authors 2014 Report on the Milestones for the US National Plan to Address Alzheimer’s DiseaseOctober 20, 2014Read more
Orion CEO & Founder Magali Haas was a co-author of the Alzheimer’s Association 2014 Report on the Milestones for the US National Plan to Address Alzheimer’s Disease. Read the full report here: http://www.alzheimersanddementia.com/article/S1552-5260(14)02791-5/fulltext
- October 20, 2014Read more
2014 KEY OPINION LEADER PROGRAM Thought leaders from industry, academia, government and medical research foundations share their insights on the opportunities and challenges that impact the discovery and development of new therapies. FRESH PERSPECTIVES AND NEW OPPORTUNITIES IN ALZHEIMER’S DISEASE THERAPEUTIC DEVELOPMENT More than 5 million Americans suffer from Alzheimer’s disease today, and without new drugs to prevent or halt
- September 30, 2014Read more
A two-hour car ride feels like 2 days when you have the same conversations about the weather and traffic, over and over. I have long mourned the loss of my mother as a friend and confidant. At 88, she is remarkably still mobile, but has been suffering from dementia for the past 8-10 years.
- September 29, 2014Read more
Orion Bionetworks founder Magali Haas was quoted in this article about financing for the study of neurological disorders.
- September 3, 2014Read more
The moment the email came in, emotion overwhelmed me. Glowing in front of my face as I sat back wide-eyed on the couch in the dark in a pair of tired gym shorts, there was a note saying I was one of a handful of people nominated by my company’s leaders for a national trade journal’s “Rising Stars” award. What luck! Completely taken aback, you can probably imagine all the feelings racing through my head… things like desperation, hopelessness, panic, anger, and shame. Wait, what?